Abstract
The aim of this study was to access the utility of the reverse transcriptase-polymerase chain reaction (RT-PCR) assay for prostatic specific membrane antigen (PSMA) in predicting non-organ confined (NOC) disease in final radical prostatectomy (RP) specimens. Nested RT-PCR for PSMA was performed on the blood of 33 patient candidates for RP, 20 patients with untreated metastatic disease and 20 healthy men. The final pathology report on the 33 RP patients was compared with the RT-PCR results and Partin nomograms. In the RP group, 4/18 patients with confined disease and 9/15 with NOC disease had positive RT-PCR assays. Sensitivity, specificity, positive and negative predictive values for RT-PCR were 60%, 77.7%, 69% and 70%, respectively. The Partin tables for this group of patients showed a sensitivity, specificity, positive and negative predictive values of 75%, 71%, 60% and 83%, respectively. P-values for the Partin tables and the RT-PCR assay were respectively 0.014 and 0.037. RT-PCR of PSMA has an independent predictive value and could help predict NOC disease in clinically localized prostate cancers, but is still less efficient than Partin tables.
Similar content being viewed by others
References
Degushi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, Kawamura T, Komeda H, Horie M, Kaji H, Shimokawa K, Tanaka T, Kawada Y (1993) Detection of micrometastatic prostate cancer cells in lymph nodes by RT-PCR. Cancer Res 53: 5350
Dumas F, Eschwege P, Blanchet P, Benoit G, Jardin A, Lacour B, Loric S (1996) Enhanced detection of hematogenous circulating prostatic cells in patients with prostatic adenocarcinoma using PSMA based nested RT-PCR assay. J Urol 155: 506A
Gomella LG, Raj GV, Moreno JG (1997) RT-PCR for PSA in the management of prostate cancer. J Urol 158: 326
Grasso Y, Gupta M, Levin H, Zippe C, Klein E (1998) Combined nested RT-PCR assay for PSA and PSMA in prostate cancer patients: correlation with pathological stage. Cancer Res 58: 1456
Gregorakis A, Holmes E, Murphy G (1998) PSMA current and future utility. Semin Urol Oncol 16: 2
Henke W, Jung M, Jung K (1996) Detection of PSA M-RNA in blood by RT-PCR does not exclusively indicate prostatic tumor cells. Clin Chem 42: 1499
Heung YM, Walsh K, Sriprasd S, Mulvin D, Sherwood RA (2000) The detection of prostate cells by the RT-PCR in the circulation of patients undergoing TUR-P. BJU Int 85: 65
Ignatoff M, Oefelein MG, Watkin W, Chmiel JS, Kaul KL (1997) Prostate specific antigen RT-PCR assay in preoperative staging of prostate cancer. J Urol 158: 1870
Israeli RS, Miller WHJr, Su SL, Samadi DS, Powell CT, Heston WDW, Wise GJ, Fair WR (1995) Sensitive detection of prostatic hematogenous micrometastasis using prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) derived primers in the polymerase chain reaction. J Urol 153: 573
Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, Buttyan R (1994) Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43: 765
Lintula S, Stenman U (1999) The expression of PSMA in peripheral blood leukocytes. J Urol 157: 1969
Loric S, Dumas F, Eschwge P, Blanchet P, Benoit G, Jardin A, Lacour B (1995) Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested RT-PCR assay based on prostate specific membrane antigen. Clin Chem 41: 1698
Mao H, Hoshi S, Takahashi T, Kaneda T, Wang J, Orikasa S (1998) Detection of PSA m-RNA from the peripheral blood and pelvic lymph nodes in-patients with prostatic cancer by means of RT-PCR. Nippon Hinyokika Gakkai Zasshi 89:596
Melchior SW, Corey E, Ellis WJ (1997): Early tumor cell dissemination in-patients with clinically localized carcinoma of the prostate. Clin Cancer Res 3: 249
Μoreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG, Gomella LG (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52: 6110
Milion R, Jacqmin D, Muller D, Guillot J, Eber M, Abecassis J (1999) Detection of PSA or PSMA circulating cells in prostatic cancer patients: clinical implications. Eur Urol 36: 278
Mukamel E, Hanna J, Dekernion JB (1987): Pitfalls in preoperative staging in prostate cancer. Urology 30: 318
Murphy GP, Ragde H, Kenny G (1995) Comparison of prostate specific membrane antigen and prostate specific antigen levels in prostate cancer patients. Anticancer Res 15: 1473
Ogawa O, Iinuma M, Sato K, Sasaki R, Shimoda N (1999) Circulating PSA m-RNA during radical prostatectomy in-patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy. Urol Res 27: 291
Ohori M, Goad JR, Wheeler TM (1994) Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 152: 1843
Okegawa T, Yoshioka J, Morita R, Nutahara K, Tsukada Y, Higashihara E (1998) Molecular staging of prostate cancer: comparison of nested reverse transcription-polymerase chain reaction assay using PSA versus PSMA as primer. Int J Urol 5: 349
Olsson CA, DeVries GM, Benson M, Raffo A, Buttyan R, Cama C, O'Toole K, Katz AE (1996) The use of RT-PCR for PSA assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer. Br J Urol 77: 411
Price D, Clontz D, Woodard W, Kaufman J, Daniels J, Stolzenberg S, Teigland C (1998) Detection and clearance of prostate cells subsequent to ultrasound-guided needle biopsy as determined by multiplex nested reverse transcription polymerase chain reaction assay. Urology 52): 261
Renneberg H, Friedetzky A, Konrad L, Kurek R, Tun W, Aumuller G (1999) PSMA is expressed in various human tissues: implications for the use of PSMA RΤ-PCR to detect hematogenous prostate cancer spread. Urol Res 27: 23
Rinker-Shaffer CW, Hawkins AL, Su SL (1995) Localization and physical mapping of the prostate specific membrane antigen (PSMA) gene to human chromosome 11. Genomics 30: 105
Saimoto A, Saito S, Murai M (1999) PSMA derived primers in a nested RT-PCR for detecting prostatic cancer cells. Jpn J Cancer Res 90: 233
Sokoloff MH, Tso CL, Kaboo R, Nelson S, Ko J, Dorey F, Figlin RA, Pang SP, DeKernion J, Belldegrun A (1996) Quantitative PCR does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol 156: 1560
Su SL, Huang IP, Fair WR (1995) Alternatively spliced variants of prostate specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res 55: 1441
Su S, Heston W, Perrotti M, Cookson M (1997) Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a RT-PCR of PSMA. Urology 49: 95
Vessela RL, Riley DE, Blouke KA, Arfman EW, Lange PH (1992) A sensitive method for detection of a prostate tumor cell marker using the polymerase chain reaction. J Urol 147 (Suppl): 441A
Yu H, Diamandis EP, Zarghami N, Grass L (1994): Induction of PSA by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 32: 219
Zhang Y, Zippe C, VanLente F (1997) Combined nested RT-PCR assay for PSA and PSMA in detecting circulating prostatic cells. Clin Can Res 3: 1215
Zippelius A, Kufer P, Honold G, Kollermann M, Oberneder R, Schlimok G, Pantel K (1997) Limitations of RT-PCR analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15: 2701
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Varkarakis, J., Deliveliotis, C., Sideris, D. et al. Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts non-organ confined disease in radical prostatectomy specimens. Urol Res 31, 183–187 (2003). https://doi.org/10.1007/s00240-003-0313-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-003-0313-6